BULLFROG AI HOLDINGS INC. - COMMON STOCK

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

29 May 2024 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

16 May 2024 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

09 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

08 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

26 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock

21 Feb 2024 11:01:05 By Nasdaq GlobeNewswire

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

09 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Closing of $5.7 Million Public Offering

05 Feb 2024 09:00:57 By Nasdaq GlobeNewswire

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

01 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

26 Jan 2024 06:30:00 By Nasdaq GlobeNewswire

BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

17 Jan 2024 06:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

16 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

11 Jan 2024 15:05:00 By Nasdaq GlobeNewswire

BullFrog AI Issues Letter to Shareholders

29 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity

06 Dec 2023 06:00:00 By Nasdaq GlobeNewswire

BullFrog AI to Present at Benzinga All Access Event on October 20

18 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

05 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma

26 Sep 2023 07:00:01 By Nasdaq GlobeNewswire

BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023

25 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform

20 Sep 2023 07:00:00 By Nasdaq GlobeNewswire